The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, open-label study of tomivosertib (eFT508) added on to continued checkpoint inhibitor therapy in patients (pts) with insufficient response to single-agent treatment.
 
Anthony B. El-Khoueiry
Honoraria - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Merck
 
Nishan Tchekmedyian
Employment - Pacific Shores Medical Group
Leadership - Pacific Shores Medical Group
Stock and Other Ownership Interests - Biomarin (I); Exelixis (I); global therapeutics (I); Halozyme (I); Infinity Pharmaceuticals (I); Portola Pharmaceuticals; Trillium Therapeutics (I)
Consulting or Advisory Role - Foundation Medicine; IntrinsiQ; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cullinan Oncology (Inst); Rain Therapeutics (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - IntrinsiQ
 
Rachel E. Sanborn
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Celldex; Genentech/Roche; Peregrine Pharmaceuticals; Seagen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - AstraZeneca; Five Prime Therapeutics; Janssen Oncology
 
Julio Antonio Peguero
Employment - Oncology Consultants
Leadership - Director, Research Department
 
Kerry Pulver
Travel, Accommodations, Expenses - eFFECTOR
 
Vikas Dembla
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Genentech; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; Sanofi/Regeneron
Travel, Accommodations, Expenses - Sanofi/Regeneron
 
Jacob Stephen Thomas
Consulting or Advisory Role - Array BioPharma
Travel, Accommodations, Expenses - eFFECTOR Therapeutics; Pfizer
 
Gary Gene Chiang
Employment - eFFECTOR Therapeutics
Stock and Other Ownership Interests - Abbvie
Research Funding - eFFECTOR Therapeutics
Travel, Accommodations, Expenses - eFFECTOR Therapeutics
 
Mark Densel
Employment - eFFECTOR Therapeutics
Stock and Other Ownership Interests - eFFECTOR Therapeutics
 
Neil Sankar
No Relationships to Disclose
 
Stephen Theodore Worland
Employment - eFFECTOR Therapeutics
Leadership - Blacksmith Medicine; eFFECTOR Therapeutics; Forge Therapeutics; TRACON Pharma
Stock and Other Ownership Interests - Bristol-Myers Squibb; eFFECTOR Therapeutics; Forge Therapeutics; GenMark Diagnostics; TRACON Pharma
Patents, Royalties, Other Intellectual Property - eFFECTOR Therapeutics; Pfizer; Roche
 
Lyon L. Gleich
Employment - Medpace
Stock and Other Ownership Interests - Medpace
Travel, Accommodations, Expenses - Medpace
 
Robert S. Sikorski
Employment - Woodside Way Ventures
Stock and Other Ownership Interests - Five Prime Therapeutics; Gossamer Bio
Consulting or Advisory Role - Woodside Way Ventures
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
Travel, Accommodations, Expenses - Woodside Way Ventures
Other Relationship - Woodside Way Ventures